Petrus Trust Company, Lta Catalent, Inc. Transaction History

Petrus Trust Company, Lta

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $143,340 - $221,783	-4,786 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $192,014 - $218,002	4,786 New	4,786 $218,000
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $190,524 - $219,918	-5,112 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $172,530 - $213,017	5,112	5,112 $204,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.